H3B-6527 |
カタログ番号GC19187 |
H3B-6527(H3バイオメディシン)は、FGF19増幅細胞株およびマウスにおいて強力な抗腫瘍活性を持つ高度選択的FGFR4阻害剤です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1702259-66-2
Sample solution is provided at 25 µL, 10mM.
H3B-6527 (H3 Biomedicine) is a highly selective FGFR4 inhibitor with potent antitumour activity in FGF19 amplified cell lines and mice.
References:
[1]. Dimitra Repana et al. Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma. Diseases 2015, 3, 294-305;
Review for H3B-6527
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)Review for H3B-6527
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *